LIPELLA PHARMACEUTICALS
Lipella Pharmaceuticals is a biotechnology company that develops products for intravesical therapy. It is a method of providing local treatments directly to the urinary bladder lumen via urethral catheterization. Indications they target include interstitial cystitis (also known as painful bladder syndrome), overactive bladder, and superficial bladder cancer. Interstitial cystitis is a chronic, painful, inflammatory condition of the bladder wall that affects over 1 million people in the United States. Its cause is unknown and there is no cure. Treatment options exist, but a majority of cases are refractive to existing therapies.
LIPELLA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Developer Platform Therapeutics
Founded:
2005-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.lipella.com
Total Employee:
1+
Status:
Active
Contact:
1-412-894-1853
Email Addresses:
[email protected]
Total Funding:
3.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Seed Round - Lipella Pharmaceuticals
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse investment in Seed Round - Lipella Pharmaceuticals
Official Site Inspections
http://www.lipella.com Semrush global rank: 4.82 M Semrush visits lastest month: 1.87 K
- Host name: 87.0.153.160.host.secureserver.net
- IP address: 160.153.0.87
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Lipella Pharmaceuticals"
Lipella Pharmaceuticals, Inc. - Empowering Cancer Survivorship
Lipella Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing treatments for serious diseases. Our proprietary drug delivery technology has …See details»
About Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing treatments for serious diseases. Our proprietary drug delivery technology has potential applications in addressing diseases of the …See details»
Corporate Overview - Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing treatments for serious diseases for which there are currently no approved …See details»
Lipella Pharmaceuticals Inc. - AnnualReports.com
Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations …See details»
Lipella Pharmaceuticals - Crunchbase Company Profile & Funding
Lipella Pharmaceuticals is a biotechnology company that develops products for intravesical therapy. It is a method of providing local treatments directly to the urinary bladder lumen via …See details»
Lipella Pharmaceuticals Inc - Prism MarketView
Jan 2, 2024 · Lipella is a biotechnology company with a focus on supportive care to cancer survivors who acquire hemorrhagic cystitis, also called radiation cystitis, when hemorrhagic cystitis occurs after pelvic radiation, as well as improved …See details»
Press Release Distribution and Management - GlobeNewswire
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose GroupSee details»
Lipella Pharmaceuticals Inc. | Life Sciences PA - Default Site
Lipella is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of lipid-based therapies for common bladder syndromes including interstitial …See details»
LIPELLA PHARMACEUTICALS, INC. | VentureRadar
Lipella Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing treatments for serious diseases, particularly those affecting mucosal …See details»
Lipella Pharmaceuticals Announces Completion of Site Initiation …
May 31, 2024 · Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these …See details»
Investors - Lipella Pharmaceuticals, Inc.
Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial; Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock; Announcing Radiation (and …See details»
Lipella Pharmaceuticals - Craft
Oct 29, 2024 · Lipella Pharmaceuticals is a biotechnology company that provides supportive care for cancer survivors. It develops liposomal formulations intended for intravesical delivery. The …See details»
Lipella Pharmaceuticals - Contacts, Employees, Board Members, …
Lipella Pharmaceuticals is a biotechnology company that develops products for intravesical therapy.See details»
Lipella Pharmaceuticals Marks Successful First Year with Strategic ...
Dec 20, 2023 · Lipella Granted Two Orphan Drug Designations by FDAPITTSBURGH, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," …See details»
Lipella Pharmaceuticals Announces Completion of First Cohort in …
Nov 21, 2024 · Seven sites across the U.S. are now active and recruiting participants for the trial. For more information, please visit https://lipella.com/oral-lichen-planus-treatment/ or...See details»
Lipella Pharmaceuticals Announces Completion of Site
May 31, 2024 · LP-310, Lipella's proprietary liposomal-tacrolimus (LP-10) oral rinse formulation, will be evaluated for safety, tolerability, and efficacy at doses of 0.25 mg, 0.5 mg, and 1.0 mg …See details»
A Clinical Stage Biotechnology Company Addressing Serious
Lipella is committed to providing supportive care to cancer survivors. Our mission is to develop and commercialize treatments for serious diseases resulting from cancer treatments including …See details»
Lipella issued patent by USPTO for liposomal drug delivery platform
Nov 12, 2024 · Lipella Pharmaceuticals (LIPO) announced that U.S. Patent No. 12,138,345 for its proprietary liposomal drug delivery platform will be officially issued by the U.S. Patent and …See details»
Lipella Pharmaceuticals Announces U.S. Patent Allowance for …
PITTSBURGH, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing therapies for serious …See details»
Lipella Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Lipella Pharmaceuticals is a biotechnology corporation that specializes in creating products for intravesical therapy. This method involves administering localized treatment directly into the …See details»